Rivastigmina

Rivastigmina / Rivastigmine

Inhibidores de la Colinesteresa || Fármacos para la Enfermedad de Alzheimer

Ficha Técnica de la EMEA. Comercializado bajo los nombres de Exelon y Prometax.

Vademecum

Bibliografía en Español



Rivastigmina: una revision de su eficacia clinica.
Revista de neurologia. 2002 Nov 1-15; 35(9): 859-69. Spiegel, R;

Rivastigmina en un caso de demencia frontotemporal, enfermedad de Pick verificada por autopsia.
Revista de neurologia. 2009 Jun 1-15; 48(11): 582-4. Calatayud-Noguera, T; Astudillo-Gonzalez, A; Alvarez-Carriles, J C; Temprano-Fernandez, T; Cortes-Velarde, M; Oliva-Nacarino, P;

Variabilidad y tendencias en el uso de farmacos contra la demencia. Estimacion de la prevalencia de la enfermedad de Alzheimer en Castilla-La Mancha.
Neurologia (Barcelona, Spain). 2010 May; 25(4): 234-8. Criado-Alvarez, J J; Romo Barrientos, C;

Alucinaciones asociadas al tratamiento con rivastigmina en dos pacientes con enfermedad difusa de cuerpos de Lewy.
Revista de neurologia. 2007 May 1-15; 44(9): 575-6. Alonso-Navarro, H; Jimenez-Jimenez, F J;

Patron de persistencia de tratamientos anticolinesterasicos en la demencia tipo Alzheimer: analisis comparativo retrospectivo de donepecilo, rivastigmina y galantamina.
Revista de neurologia. 2004 Aug 16-31; 39(4): 312-6. Sicras, A; Rejas-Gutierrez, J;

Analisis comparativo de los patrones de persistencia de medicaciones antidemencia en una cohorte retrospectiva de pacientes con demencia de tipo Alzheimer tratados con donepecilo, rivastigmina, galantamina y memantina en Espana.
Revista de neurologia. 2006 Oct 16-31; 43(8): 449-53. Sicras-Mainar, A; Vergara, J; Leon-Colombo, T; Febrer, L; Rejas-Gutierrez, J;

Habitos de prescripcion de rivastigmina en solucion en pacientes con demencia de tipo Alzheimer en Espana (estudio RIVASOL).
Revista de neurologia. 2007 Jun 16-30; 44(12): 705-10. Gonzalez-Gutierrez, J L; Gobartt, A L;

Utilizacion de los inhibidores de la acetilcolinesterasa y la memantina para el tratamiento clinico de la demencia tipo Alzheimer.
Revista espanola de salud publica. 2005 Nov-Dec; 79(6): 665-72. Portela Romero, Manuel; Pombo Romero, Julio; Bugarin Gonzalez, Rosendo; Tasende Souto, Margarita; Represa Veiga, Silvia;

Medicamentos transdermicos en neurologia.
Neurologia (Barcelona, Spain). 2007 Jul-Aug; 22(6): 416. Duran Ferreras, E; Martinez-Parra, C; Duran Quintana, J A;

Estudio comparativo de la efectividad y tolerabilidad de un procedimiento de escalado lento de dosis de rivastigmina en pacientes con demencia tipo Alzheimer leve o moderada: estudio SCALEX.
Rev Neurol. 2008 May 1-15;46(9):517-24. Aguera-Ortiz L.F., Ramos-Garcia M., Gobartt A.L.

Evaluation of the convenience of changing the rivastigmine administration route in patients with Alzheimer disease.
Neurologia (Barcelona, Spain). 2011 Jun; 26(5): 262-71. Blesa Gonzalez, R; Boada Rovira, M; Martinez Parra, C; Gil-Saladie, D; Almagro, C A; Gobartt Vazquez, A L;

Tolerancia y acontecimientos adversos del tratamiento con inhibidores de la acetilcolinesterasa en una muestra clinica de pacientes con enfermedad de Alzheimer de gravedad minima y leve durante un periodo de seis meses.
Revista de neurologia. 2003 Mar 1-15; 36(5): 421-4. Turon-Estrada, A; Lopez-Pousa, S; Gelada-Batlle, E; Garre-Olmo, J; Lozano-Gallego, M; Hernandez-Ferrandiz, M; Fajardo-Tibau, C; Morante-Munoz, V; Vilalta-Franch, J;

Cambio de anticolinesterasico en la enfermedad de Alzheimer.
Revista de neurologia. 2005 Jun 16-30; 40(12): 739-42. Olazaran-Rodriguez, J; Navarro-Merino, E;



Subir

Bibliografía: Ensayos Randomizados en CoreClinical Journals



Behavioral symptoms in mild cognitive impairment.
Neurology. 2004 Apr 13; 62(7): 1199-201. Feldman, H; Scheltens, P; Scarpini, E; Hermann, N; Mesenbrink, P; Mancione, L; Tekin, S; Lane, R; Ferris, S;

Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease.
Neurology. 2004 Dec 28; 63(12): 2348-53. Olazaran, J; Muniz, R; Reisberg, B; Pena-Casanova, J; del Ser, T; Cruz-Jentoft, A J; Serrano, P; Navarro, E; Garcia de la Rocha, M L; Frank, A; Galiano, M; Fernandez-Bullido, Y; Serra, J A; Gonzalez-Salvador, M T; Sevilla, C;

Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease.
Neurology. 2007 Jul 24; 69(4): S23-8. Blesa, Rafael; Ballard, Clive; Orgogozo, Jean-Marc; Lane, Roger; Thomas, Simu K;

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.
BMJ (Clinical research ed.). 1999 Mar 6; 318(7184): 633-8. Rosler, M; Anand, R; Cicin-Sain, A; Gauthier, S; Agid, Y; Dal-Bianco, P; Stahelin, H B; Hartman, R; Gharabawi, M;

No additional benefit of HRT on response to rivastigmine in menopausal women with AD.
Neurology. 2003 Jan 14; 60(1): 148-9. Rigaud, A S; Andre, G; Vellas, B; Touchon, J; Pere, J J;

Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients.
Clinical pharmacology and therapeutics. 2008 Jan; 83(1): 106-14. Lefevre, G; Sedek, G; Jhee, S S; Leibowitz, M T; Huang, H-La; Enz, A; Maton, S; Ereshefsky, L; Pommier, F; Schmidli, H; Appel-Dingemanse, S;

IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease.
Neurology. 2007 Jul 24; 69(4): S14-22. Winblad, B; Grossberg, G; Frolich, L; Farlow, M; Zechner, S; Nagel, J; Lane, R;

Benefits of rivastigmine on attention in dementia associated with Parkinson disease.
Neurology. 2005 Nov 22; 65(10): 1654-6. Wesnes, K A; McKeith, I; Edgar, C; Emre, M; Lane, R;

Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine.
Brain : a journal of neurology. 2003 Dec; 126(0): 2750-60. Parry, Allyson M M; Scott, Richard B; Palace, Jacqueline; Smith, Stephen; Matthews, Paul M;

Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
Neurology. 2006 Sep 12; 67(5): 748-55. Silver, J M; Koumaras, B; Chen, M; Mirski, D; Potkin, S G; Reyes, P; Warden, D; Harvey, P D; Arciniegas, D; Katz, D I; Gunay, I;

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.
Lancet. 2010 Nov 27; 376(9755): 1829-37. van Eijk, Maarten M J; Roes, Kit C B; Honing, Marina L H; Kuiper, Michael A; Karakus, Attila; van der Jagt, Mathieu; Spronk, Peter E; van Gool, Willem A; van der Mast, Roos C; Kesecioglu, Jozef; Slooter, Arjen J C;

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.
Lancet. 2000 Dec 16; 356(9247): 2031-6. McKeith, I; del Ser, T; Spano, P; Emre, M; Wesnes, K; Anand, R; Cicin-Sain, A; Ferrara, R; Spiegel, R;

Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study.
Neurology. 2013 Feb 5; 80(6): 553-60. Simioni, Samanta; Cavassini, Matthias; Annoni, Jean-Marie; Metral, Melanie; Iglesias, Katia; Rimbault Abraham, Aline; Jilek, Samantha; Calmy, Alexandra; Muller, Hubertus; Fayet-Mello, Aurelie; Giacobini, Ezio; Hirschel, Bernard; Du Pasquier, Renaud A;

Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression.
Archives of neurology. 2001 Mar; 58(3): 417-22. Farlow, M R; Hake, A; Messina, J; Hartman, R; Veach, J; Anand, R;

Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery--a randomized controlled trial.
Critical care medicine. 2009 May; 37(5): 1762-8. Gamberini, Melanie; Bolliger, Daniel; Lurati Buse, Giovanna A; Burkhart, Christoph S; Grapow, Martin; Gagneux, Alexa; Filipovic, Miodrag; Seeberger, Manfred D; Pargger, Hans; Siegemund, Martin; Carrel, Thierry; Seiler, Walter O; Berres, Manfred; Strebel, Stephan P; Monsch, Andreas U; Steiner, Luzius A;

Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.
Archives of neurology. 2003 Jun; 60(6): 843-8. Farlow, Martin; Potkin, Steven; Koumaras, Barbara; Veach, Jeffrey; Mirski, Dario;

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.
BMJ (Clinical research ed.). 2005 Apr 16; 330(7496): 874. Ballard, Clive; Margallo-Lana, Marisa; Juszczak, Edmund; Douglas, Simon; Swann, Alan; Thomas, Alan; O'Brien, John; Everratt, Anna; Sadler, Stuart; Maddison, Clare; Lee, Lesley; Bannister, Carol; Elvish, Ruth; Jacoby, Robin;

Rivastigmine for dementia associated with Parkinson's disease.
The New England journal of medicine. 2004 Dec 9; 351(24): 2509-18. Emre, Murat; Aarsland, Dag; Albanese, Alberto; Byrne, E Jane; Deuschl, Gunther; De Deyn, Peter P; Durif, Franck; Kulisevsky, Jaime; van Laar, Teus; Lees, Andrew; Poewe, Werner; Robillard, Alain; Rosa, Mario M; Wolters, Erik; Quarg, Peter; Tekin, Sibel; Lane, Roger;


Subir